Originally published by: JSI
Original author: Kate Bagshaw and Nicole Davis
Originally published on: January 29, 2020

HPV Vaccination in Kenya during COVID


Worldwide, countries are developing and implementing strategies to introduce COVID-19vaccines. JSI’s experience with life-course vaccination, notably supporting the preparation and introduction of the human papillomavirus (HPV) vaccine in eight countries, can be adapted to provide technical assistance for COVID-19 vaccine introduction. Three key lessons have emerged.